Intracerebroventricular administration of the thyroid hormone analog TRIAC increases its brain content in the absence of MCT8.
Patients lacking the thyroid hormone (TH) transporter MCT8 present abnormal serum levels of TH: low thyroxine and high triiodothyronine. They also have severe neurodevelopmental defects resulting from cerebral hypothyroidism, most likely due to impaired TH transport across the brain barriers. The us...
Main Authors: | Soledad Bárez-López, Carmen Grijota-Martínez, Xiao-Hui Liao, Samuel Refetoff, Ana Guadaño-Ferraz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0226017 |
Similar Items
-
Intranasal delivery of Thyroid hormones in MCT8 deficiency.
by: Carmen Grijota-Martínez, et al.
Published: (2020-01-01) -
MCT8 Deficiency: The Road to Therapies for a Rare Disease
by: Carmen Grijota-Martínez, et al.
Published: (2020-04-01) -
Thyroid Hormone Availability and Action during Brain Development in Rodents
by: Soledad Bárez-López, et al.
Published: (2017-08-01) -
Increased oxidative metabolism and neurotransmitter cycling in the brain of mice lacking the thyroid hormone transporter SLC16A2 (MCT8).
by: Tiago B Rodrigues, et al.
Published: (2013-01-01) -
Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
by: Theresa Porst, et al.
Published: (2021-04-01)